Search

Author/Creator Swain, Mark G

3. Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression. Issue 9 (18th October 2018)

Authors:
Frolkis, Alexandra D; Vallerand, Isabelle A; Shaheen, Abdel-Aziz; Lowerison, Mark W; Swain, Mark G; Barnabe, Cheryl; Patten, Scott B; Kaplan, Gilaad G
Journal:
Gut
Issue:
Volume 68:Issue 9(2019)
Page Start:
1606
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Risk Factors for Mortality in Patients with Alcoholic Hepatitis and Assessment of Prognostic Models: A Population-Based Study. Issue 3 (2015)

Authors:
Pang, Jack XQ; Ross, Erin; Borman, Meredith A; Zimmer, Scott; Kaplan, Gilaad G; Heitman, Steven J; Swain, Mark G; Burak, Kelly; Quan, Hude; Myers, Robert P
Journal:
Canadian journal of gastroenterology & hepatology
Issue:
Volume 29:Issue 3(2015)
Page Start:
131
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study. (October 2017)

Authors:
Jones, David; Boudes, Pol F; Swain, Mark G; Bowlus, Christopher L; Galambos, Michael R; Bacon, Bruce R; Doerffel, Yvonne; Gitlin, Norman; Gordon, Stuart C; Odin, Joseph A; Sheridan, David; Wörns, Markus-Alexander; Clark, Virginia; Corless, Linsey; Hartmann, Heinz; Jonas, Mark E; Kremer, Andreas E...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 2:Number 10(2017)
Page Start:
716
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗